Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 2441 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Calliditas Therapeutics to Attend Conferences in April

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Calliditas Therapeutics AB

Medivir to present at Investing in Oncology Forum on April 10

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Medivir AB

HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024

VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Valeo Pharma Inc.

Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Numinus Wellness Inc.

Héma-Québec opens 12th donor centre in Québec

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Héma-Québec

Nanostics and Alberta Health Services collaborate to develop new diagnostic tools for urological diseases

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Nanostics Inc

ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  ESSA Pharma Inc.

Go-To-Market Success: The Role of Capital Preservation in Life Science Research and Diagnostic Consumable Manufacturing, Upcoming Webinar Hosted by Xtalks

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Xtalks

Drainage Solutions to Enhance Product Safety for the F&B and Pharma Industries, Upcoming Webinar Hosted by Xtalks

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Xtalks

enGene Announces Hiring of Dr. Raj Pruthi as Senior Vice President, Urologic Oncology and Clinical Development

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  enGene Holdings Inc.

Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics

Read more ››
By: GlobeNewswire - 09 Apr 2024
Related companies:  Basilea Pharmaceutica International Ltd

EssilorLuxottica closes the acquisition of Washin to grow its optical retail presence in Japan

Read more ››
By: GlobeNewswire - 09 Apr 2024
Related companies:  EssilorLuxottica

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma

Read more ››
By: GlobeNewswire - 09 Apr 2024
Related companies:  Essential Pharma Ltd

Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Nanoform Finland Oyj

KIDRON Capital Assets Announces First Close of Women's Health VC Fund

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024

Medit Unveils i900: The Next Evolution of Intraoral Scanners

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  Meditope Biosciences, Inc.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved pulsed field ablation system

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024

American Lung Association and LUNGevity Foundation Announce $3 Million Research Partnership to Intercept Lung Cancer

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  American Lung Association

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Read more ››
By: PR Newswire Association LLC. - 09 Apr 2024
Related companies:  BrainStorm Cell Therapeutics Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑